72
Participants
Start Date
March 1, 2017
Primary Completion Date
March 16, 2022
Study Completion Date
March 16, 2022
Metoprolol Tartrate Oral Tablet
Metoprolol is a beta-blocker commonly used for mild blood pressure control, and also commonly used for migraine. Subjects with IC/BPS or MPP will start metoprolol at 25 mg once daily and increase to the goal dose of 25 mg 2/day after one week and continue for 8 weeks total.
Placebo Oral Tablet
Subjects with IC/BPS or MPP will start placebo distributed in a double-blind manner. Subjects will take placebo once daily and increase to the goal dose of 25 mg 2/day after one week and continue for 8 weeks total.
No intervention- observational sub-study
Participants did not receive placebo or metoprolol during the entire duration of the study.
Virginia Commonwealth University, Richmond
NorthShore University HealthSystem, Evanston
Collaborators (1)
Endeavor Health
OTHER
Case Western Reserve University
OTHER
Virginia Commonwealth University
OTHER